Antiviral activity of molnupiravir precursor NHC against SARS-CoV-2 Variants of Concern (VOCs) and its therapeutic window in a human lung cell model

T Prince, I Donovan-Banfield, H Goldswain… - bioRxiv, 2021 - biorxiv.org
Synopsis Background The UK Medicines and Regulatory Healthcare Agency (MHRA) have
recently licensed the anti-viral drug, molnupiravir, for use in patients with mild-moderate …
被引用次数：12 相关文章

Antiviral activity of molnupiravir precursor NHC against SARS-CoV-2 Variants of Concern (VOCs) and its therapeutic window in a human lung cell model

T Prince, H Goldswain, R Penrice-Randal, L Turtle… - bioRxiv, 2021 - biorxiv.org
Synopsis Background The UK Medicines and Regulatory Healthcare Agency (MHRA) have
recently licensed the anti-viral drug, molnupiravir, for use in patients with mild-moderate …

Antiviral activity of molnupiravir precursor NHC against Variants of Concern (VOCs) and its therapeutic window in a human lung cell model

T Prince, H Goldswain, R Penrice-Randal, L Turtle… - 2021 - pesquisa.bvsalud.org
Antiviral activity of molnupiravir precursor NHC against Variants of Concern (VOCs) and its
therapeutic window in a human lung cell model | PREPRINT-BIORXIV loading 1 2 3 +A A -A …